The Future of Dental Healing: What Is Regenerative Endodontics?

Where Regenerative Endodontics Is Heading

Regenerative endodontic procedures, sometimes called REPs or pulp revascularization, are now an established treatment option for a specific group of teeth: immature permanent teeth in which the pulp has died, most often as a result of trauma or infection in children, teenagers, and young adults. For this patient population, the procedure has moved from research protocol to standard clinical option over roughly the last fifteen years. The longer-term question is what the field looks like as research continues, what realistic improvements are likely in the next several years, and which possibilities discussed in the research literature remain experimental for the foreseeable future. This article covers what is currently established, what is changing, and what is still some distance away.

What Is Currently Established

Current regenerative endodontic protocols, supported by the clinical guidelines published by the American Association of Endodontists, follow a standardized two-visit sequence. At the first visit, the canal is accessed and gently disinfected with low-concentration irrigants selected to reduce bacteria while preserving the viability of stem cells in the surrounding tissues. An intracanal medication is placed for several weeks. At the second visit, the medication is removed, bleeding is induced from the tissues at the root tip to form a scaffold within the canal, and a biocompatible material is placed to seal the coronal portion of the canal. The tooth is then monitored over months and years with follow-up imaging.

Reported outcomes from this protocol are favorable for the goals that are most clinically important. Resolution of symptoms and signs of infection occurs in the substantial majority of treated teeth, with reported rates commonly in the 90 percent range across multiple studies. Continued root development, including thickening of the canal walls and closure of the root tip, occurs in a meaningful percentage of cases but is more variable, with success defined by these stricter criteria producing lower reported rates. Return of normal pulp sensation is uncommon, and histological studies of teeth that have undergone the procedure consistently show that the tissue forming in the canal is not true pulp but a mixture of cementum, bone, and connective tissue.

The current state of the field is therefore best understood as a procedure that reliably resolves infection and supports continued root development in many cases, that produces variable degrees of structural improvement, and that does not regenerate true pulp tissue. This is meaningful clinical progress for a patient population that previously had limited options, and it is also less dramatic than the field is sometimes presented as.

What Is Likely to Improve in the Near Term

Several areas of active research are producing changes that are likely to reach clinical practice within the next several years rather than remaining indefinitely in the lab.

Scaffold materials are an active area of development. The current protocol uses an induced blood clot as the scaffold within the canal, which is straightforward to produce but variable in its composition and behavior from case to case. Alternative scaffold materials, including platelet-rich plasma and platelet-rich fibrin derived from the patient's own blood, and synthetic scaffolds designed specifically for this application, are being studied as alternatives that may produce more consistent results. Some of these are already in clinical use in selected cases, and broader adoption is likely as more outcome data becomes available.

Standardization of clinical protocols is a less glamorous development but a significant one. Variation in irrigation protocols, intracanal medications, and timing between visits has made it difficult to compare results across studies and contributed to the variability of reported outcomes. The publication of consensus guidelines and ongoing refinement of those guidelines as new evidence emerges is gradually reducing this variability and producing more consistent outcomes from one practice to another.

Improvements in imaging, particularly cone beam CT, allow root development to be monitored more accurately over time than was possible with conventional radiographs. The ability to measure small changes in canal wall thickness and root length precisely supports both clinical follow-up of individual cases and outcome studies that generate the evidence base for the field.

Better understanding of case selection is also producing more predictable results. The early years of regenerative endodontic practice involved a broad range of case types and indications, with corresponding variability in outcomes. The current understanding of which teeth are best suited to the procedure, including specific criteria related to the stage of root development, the absence of fracture, the condition of the surrounding tissues, and the patient's age, has tightened. Outcomes for appropriately selected cases are better than for cases selected by broader criteria.

What Remains Some Distance Away

Several possibilities discussed in the research literature are sometimes presented as near-term developments but are realistically further out.

Cell-based approaches, in which stem cells are delivered directly into the canal rather than being recruited from the surrounding tissues, are an active area of laboratory research. Several sources of stem cells have been studied, including dental pulp stem cells, stem cells from the apical papilla, and stem cells from bone marrow and other tissues. Clinical translation of these approaches involves regulatory, technical, and economic considerations that are unlikely to resolve quickly, and these approaches remain primarily in the research domain for the foreseeable future.

Engineered pulp tissue grown outside the body and transplanted into a tooth is a possibility discussed in the research literature but is several steps removed from clinical practice. The technical requirements for producing functional pulp tissue with appropriate vascularization, nerve supply, and integration with the surrounding structures are substantial, and demonstrating that such tissue would actually outperform current protocols in clinical use is a separate question from whether it can be produced in the laboratory.

Gene-based approaches, in which the expression of specific genes is modified to direct tissue formation, are at an even earlier stage. The regulatory pathway for clinical use of gene therapy is considerably more involved than for other dental procedures, and the specific application to endodontic regeneration would need to compete with applications in fields where the clinical need is more pressing. Realistic timelines for clinical translation are measured in decades rather than years.

Application of regenerative protocols to fully mature adult teeth is an area where research is ongoing but where current evidence does not support routine clinical use. The biological basis for regeneration in an immature tooth, with its rich apical blood supply and active developmental tissues, differs from the situation in a fully developed tooth, and protocols optimized for one situation may not produce equivalent results in the other.

What This Means for Current Patients

For a young patient with an immature tooth and a dead pulp, particularly following dental trauma, regenerative endodontic treatment is an established option that should be considered alongside conventional alternatives such as apexification. The procedure is supported by sufficient clinical evidence to be offered as a reasonable choice in appropriately selected cases, and the realistic range of outcomes can be discussed with the patient and family before treatment begins.

For a patient with a fully developed adult tooth and a pulp problem that requires treatment, conventional root canal therapy remains the standard of care. Regenerative protocols in this setting are not supported by sufficient evidence to be offered as a routine alternative, and presenting them otherwise is misleading.

For the field as a whole, the next five to ten years are likely to bring incremental rather than transformative changes. Refinements in scaffold materials, standardization of protocols, improvements in case selection, and a slowly growing evidence base for variant approaches are the realistic expectations. The larger possibilities discussed in the research literature, including engineered tissue and gene-based approaches, remain longer-term prospects rather than near-term clinical realities.

This is a less dramatic picture than regenerative endodontics is sometimes presented as offering, and it is also a more honest one. The procedure is genuinely useful for the patient population it serves, the science behind it continues to develop in productive directions, and patients and families are best served by understanding both what the current procedure can accomplish and what realistic future developments are likely to look like.

About Tri-City Endodontics

Dr. Malhan and the Tri-City Endodontics team have practiced in Pasco for more than 25 years and receive referrals from general dentists and pediatric dentists throughout the Tri-Cities region for immature permanent teeth in which preserving the potential for continued root development is a priority. Each case is evaluated individually, since regenerative treatment is best suited to specific clinical situations and is not appropriate for every tooth with pulp necrosis. Patients and parents are informed of the realistic range of outcomes before treatment begins, including the outcomes that are well supported by current evidence and those that remain less predictable, so decisions are made with a clear understanding of what the procedure can and cannot accomplish